Agile Therapeutics Shares Continue Rebound From $1.04 Pre-Market Low Fri.; Move Comes Despite 2 Downgrades Tues. Morn.; Stock Fell ~60% At Open Fri. Following News Of CRL From FDA For Twirla NDA; Shares Have Rebounded By ~176% Since Fri. Low